Biocon Biologics Limited, a subsidiary of Biocon Limited, is a fully integrated global biosimilars organization. It is leveraging cutting-edge science, innovative tech platforms and advanced research & development capabilities to lower treatment costs while improving healthcare outcomes. 

It has a strong research pipeline of biosimilar molecules across diabetes, oncology, immunology, and other non-communicable diseases. Six molecules from Biocon Biologics’ portfolio have been taken from lab to market in developed markets like United States, EU, Australia, Canada and Japan. 

With a team of ~ 4,800 people, Biocon Biologics is committed to transforming healthcare and transforming lives by enabling affordable access to millions of patients’ worldwide. 

Follow-us on Twitter:  @BioconBiologics

Biotechnology

Life Sciences

Pharmaceutical

Biocon Biologics

Shreehas Tambe

Arshad Jamil

Mandar Ghatnekar

Amol Mudgalkar

Stephen J. Fecho

Seema Ahuja

Paul Vazhayil Thomas

Mandar S Ghatnekar

Ganesh Reddy

David Gibson

Arlene Wolny

Anuj Goel

Uwe Gudat

Susheel Umesh

Sandeep N. Athalye

Rhonda Duffy

Matthew Erick

Kedar Upadhye

Dwight D. Hanshew

The Operations Team at Biocon Biologics is responsible for ensuring the seamless execution of manufacturing, production, and supply chain processes for the company’s biosimilar products. The team oversees digital transformation, process automation, quality control, and project management to optimize efficiency and maintain high standards. They collaborate closely with various departments to support the company’s goal of providing affordable and accessible healthcare solutions globally.

Operations Team

Global Operations Team

Leadership Team

Scientific Research and Development

Operations Team

About

Team members

Other teams at Biocon Biologics

Global Operations Team

Leadership Team

Scientific Research and Development